Category Archives: AZBio News
Scientists reveal low-cost, paper-based test for Zika
Hoping to foil Zika’s rapid advance, researchers from the Wyss Institute in Boston, along with colleagues from Arizona State University, have developed a low-cost, practical diagnostic that can be easily administered, even in areas where resources and medical expertise are scarce.Continue reading
Help Is Just a Phone Call Away – Telephone CPR Improves Cardiac Arrest Outcomes, UA Research Finds
“These outcomes demonstrate that it is feasible to save lives from cardiac arrest through implementing and measuring this key intervention of Telephone-CPR instructions delivered by 9-1-1 dispatchers,” said UA Emergency Medicine researcher Dr. Bentley J. Bobrow.Continue reading
IMS Health and Quintiles to Merge
Quintiles IMS to Become Industry-Leading Information and Technology-Enabled Healthcare Service Provider
TGen SU2C Melanoma Dream Team member receives $200,000 Sharp Award
Sharp Innovation in Collaboration Award recognizes teamwork and development of new ideas among SU2C researchersContinue reading
Making Precision Medicine a Reality: Genomics Researchers Discover Road Map to Disease Origin
University of Arizona Health Sciences, University of Pennsylvania and Vanderbilt University researchers are one step closer to understanding the genetic and biological basis of diseases like cancer, diabetes, Alzheimer’s and rheumatoid arthritis – and to identifying new drug targets and therapies.Continue reading
Zimmer Biomet to Acquire Cayenne Medical
Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, announced today that it has entered into a definitive agreement to acquire Scottsdale, Arizona-based Cayenne Medical, Inc. The transaction, which is subject to customary closing conditions, is expected to close during the second quarter of 2016. The financial terms of the transaction were not disclosed. Continue reading
Beacon Biomedical Inc. Appoints Industry Veteran To Lead Cancer Screening Technology Commercialization
Phoenix, AZ – April 25, 2016: Beacon Biomedical, Inc., a privately held company focused on developing highly accurate laboratory and point-of-care blood tests for early colorectal cancer screening, announced that it has appointed Dave English as Director of Business Development.Continue reading
TGen tracks the origins and spread of potentially deadly Valley Fever
Latest in genomic technologies could track sources of future infectious outbreaksContinue reading